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Background: Urban air pollution is an increasing health problem, particularly in Asia, where the combustion of
fossil fuels has increased rapidly as a result of industrialization and socio-economic development. The adverse
health impacts of urban air pollution are well established, but less is known about effective intervention strategies.
In this demonstration study we set out to establish methods to assess whether wearing an R95 activated carbon
respirator could reduce intake of polycyclic aromatic hydrocarbons (PAH) in street workers in Hanoi, Vietnam.
Methods: In this demonstration study we performed a cross-over study in which non-smoking participants that
worked at least 4 hours per day on the street in Hanoi were randomly allocated to specific respirator wearing
sequences for a duration of 2 weeks. Urines were collected after each period, i.e. twice per week, at the end of the
working day to measure hydroxy PAHs (OH-PAH) using gas chromatography/high resolution mass spectrometry.
The primary endpoint was the urinary concentration of 1-hydroxypyrene (1-OHP).
Results: Forty-four participants (54.5% male, median age 40 years) were enrolled with the majority being motorbike
taxi drivers (38.6%) or street vendors (34.1%). The baseline creatinine corrected urinary level for 1-OHP was much
higher than other international comparisons: 1020 ng/g creatinine (IQR: 604–1551). Wearing a R95 mask had no
significant effect on 1-OHP levels: estimated multiplicative effect 1.0 (95% CI: 0.92-1.09) or other OH-PAHs, except
1-hydroxynaphthalene (1-OHN): 0.86 (95% CI: 0.11-0.96).
Conclusions: High levels of urine OH-PAHs were found in Hanoi street workers. No effect was seen on urine
OH-PAH levels by wearing R95 particulate respirators in an area of high urban air pollution, except for 1-OHN. A
lack of effect may be de to gaseous phase PAHs that were not filtered efficiently by the respirator. The high levels
of urinary OH-PAHs found, urges for effective interventions.
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Urban air pollution is an increasing health problem in
Asia, where the combustion of fossil fuels has increased
rapidly as a result of industrialization and socio-economic
development [1-5]. Combustion produces a complex mix-
ture of pollutants consisting of primary emissions and
products of atmospheric transformation [4,6]. It is esti-
mated that air pollution in urban areas worldwide causes
approximately 3% of adult cardiopulmonary disease deaths
approximately 5% of mortality from malignancies of the
respiratory tract, and about 1% of mortality from acute re-
spiratory illness (ARI) in children [4]. This results in 0.80
million premature deaths with 6.4 million years of life lost
(YLL) and occurs predominantly in developing coun-
tries, with 20%-39% of attributable YLL in the South East
Asia Region [4]. To date, most studies on health and
urban air pollution have been performed in developed
countries, where pollution levels are generally within the
limits considered by WHO to be safe [6]. It is essential to
study the health impacts of air pollution in the large cities
of Asia where air pollution levels exceed WHO standards
and to develop interventions to reduce the burden of asso-
ciated morbidity and mortality.
According to the Global Environment Outlook released
by the United Nations Environment Program in October
2007, both Hanoi and Ho Chi Minh City, Vietnam, have
serious problems with air pollution, with pollution para-
meters exceeding WHO standards [7]. The Vietnamese
Ministry of Natural Resources and Environment (MoNRE)
estimated that traffic emissions are responsible for 70% of
all air pollution, 85% of carbon monoxide (CO) and 96%
of volatile organic compounds [7]. The levels of respirable
particulate matter, with a particle size of < 10 μm (PM10),
in 2004 in several Hanoi districts exceeded the limits of
the WHO threshold of 50 μg/m3 up to five fold [7]. Since
that study there has been further rapid urbanization in
Hanoi and massive expansion in the number of motor
vehicles. One study in Vietnam measured atmospheric
polycyclic aromatic hydrocarbons (PAHs) at 10 different
roadside sites in Hanoi in August 2005 [8]. The concen-
trations reported are significantly higher than those from
other countries, often exceeding recommended maximum
thresholds by the WHO. The measured atmospheric
PAHs mainly originated from motorcycles without cata-
lytic converters [8].
Long-term exposure to urban air pollution has been
associated with mutagenesis and cancer whereas short-
term exposure has been associated with pulmonary in-
flammation, increased susceptibility to bacterial and viral
infections, allergens and increased susceptibility to lung
damage [9-11]. Current evidence of an impact on human
health has been mostly indirect and comes largely from
ecological studies [9,12,13], which although well conducted,
do not provide evidence for causal associations. Limitedcohort studies provide more direct evidence but still have
not been able to establish a causal relationship [14].
Urban air pollution is likely to increase, especially in
the Asian region, where urban air pollution contributes
to 500,000 premature deaths annually [7]. Interventions
to prevent disease and mortality in regions with high
urban air pollution levels are urgently required. Com-
bustion of gasoline and diesel fuels releases particulates
and PAHs and in Hanoi motor vehicles have been the
major source of PAHs [15]. In this demonstration study
we set out to determine the PAH intake of workers in
high traffic areas of Hanoi by measuring PAH metabo-
lites (OH-PAHs) in the urine and to pilot whether the
PAH intake can be reduced by wearing a particulate res-
pirator that can filter particulate bound PAHs [16-19].
Particulate respirators (e.g. N95 or R95) that can effi-
ciently filter particulate matter, have shown to reduce
OH-PAHs in industrial settings, however have never been
tested in a community based setting with high PAH levels
[20-22].
Methods
Study site and study population
This demonstration study was conducted by the National
Institute of Occupational and Environmental Health
(NIOEH) in Hanoi, Vietnam. The target population was
healthy adult volunteers that worked outside on the
streets of Hanoi for at least 4 hours per day. Exclu-
sion criteria include other PAH exposures that may lead
to increased OH-PAHs levels in the urine: smoking to-
bacco, cooking at home with biomass fuel, unwilling to
stop eating grilled food during study period. Also failing
the respirator mask fit test was an exclusion criterion.
Institutional Review Board approval was obtained from
Oxford University Tropical Research Ethics Committee
(OXTREC) and NIOEH, and was added to the trial re-
gistry under number ISRCTN74390617. Written informed
consent was obtained from all participants.
Study intervention and design
The intervention consisted of wearing a R95 particulate
respirator (9913 K respirator, 3 M, USA) with a filtration
efficiency of at least 95% when tested with 0.3 mm dioc-
tyl phthalate aerosols. The respirator has activated car-
bon to reduce nuisance levels of odours, and has an
adjustable nose clip for better fit and for preventing fog-
ging of eye wear. The activated carbon has been shown
to be able to filter vapours, like toluene and benzene,
with a 10% breakthrough value of at least 60 minutes
[23]. All participants were instructed on how to wear the
mask and were required to pass the respirator ‘fit test’
using the ‘saccharin solution aerosol protocol’ according
to the Occupational Safety & Health Administration (USA)
guidelines [24].
Wertheim et al. Environmental Health 2012, 11:72 Page 3 of 9
http://www.ehjournal.net/content/11/1/72Urine 1-hydroxypryrene (1-OHP) concentration was
chosen as the primary endpoint in this study because it is
the metabolite of pyrene, a common component of PAH
mixtures, and is a good biological indicator of PAH expo-
sure [15,25-27]. The median half-life of urine 1-OHP was
estimated recently to be 3.9 hours, but can vary and be up
to 18 h depending on the exposure [25,28]. We used a
cross-over study design to study the effect of wearing R95
respirators in which participants were randomly allocated
to specific respirator wearing sequences: ABBA or BAAB,
where ‘A’ is wearing the respirator for two consecutive
days during working hours and ‘B’ is not wearing the res-
pirator for two consecutive days (Table 1). We chose two
days as previous work showed that OH-PAHs return to
their baseline levels within 24–48 hours after the exposure
[28]. A new respirator was provided for each day a mask
was to be worn. Compliance was assessed through weekly
unannounced visits and checks by study team members.
Furthermore, reminder text messages were sent to the
mobile phones of the participants when they needed to
wear the mask. Participants were asked to note in their
diary whether they wore the mask or not.
Data and urine specimen collection
The following data were collected from the participants:
age, sex, occupation, medical history, weight, smoking
behavior, living conditions, and prior use of a face mask
unrelated to the study. A daily diary was kept with the fol-
lowing assessments: respiratory symptoms (sneezing, nasal
congestion, nasal discharge, throat pain, cough, dyspnea,
eye irritation, other), respirator comfort, food consumed,
time start/stop working, and distance driven onTable 1 Study profile
Day Group ABBA Group BAAB
Friday Evening urine Evening urine
Weekend No intervention No intervention
Monday Wear respirator No respirator




Wednesday No intervention No intervention
Thursday No respirator Wear respirator




Weekend No intervention No intervention
Monday No respirator Wear respirator




Wednesday No intervention No intervention
Thursday Wear respirator No respirator
Friday Wear respirator, evening
urine
No respirator, evening
urinemotorbike. Urine specimens (10 to 20 mL) were collected
on Tuesday and Friday afternoon by the participant in a
labeled sterile container (Table 1). The urine specimens
were immediately transported on ice and frozen at −80°C
until testing.
OH-PAH analysis in urine
At the end of the study, collected urine samples were
shipped on dry ice to the Centers for Disease Control
and Prevention (CDC), Atlanta, USA for analysis of
OH-PAHs using gas chromatography/high resolution
mass spectrometry (GC-HRMS) according to previous
described methods [29]. The methodology for measuring
OH-PAH metabolites, present in human urine as glucur-
onide and/or sulfate conjugates, is based on enzymatic
deconjugation of the analytes to yield free OH-PAHs,
followed by automatic liquid-liquid extraction into pen-
tene using the Gilson 215 Liquid Handler (Gilson Inc.,
Middleton, WI). The sample extracts are thereafter evapo-
rated under a chemical fume hood to remove the pentene
solvent. Finally, the extracts are re-constituted in toluene,
derivatized to yield the trimethylsiloxane derivatives. Ana-
lytical determination of the target analytes were per-
formed by gas chromatography isotope dilution high
resolution mass spectrometry (GC-IDHRMS) employing a
MAT95XP (ThermoFinnigan MAT, Bremen, Germany)
instrument. Creatinine concentration was measured to
control for the effect of fluid intake and loss and adjust
OH-PAH concentrations accordingly.
Cotinine urine analysis
Cotinine concentrations were measured at NIOEH to
detect participants who were exposed to high levels of
tobacco smoke. The urine samples (5 mL) were added to
sodium hydroxide (5 M, 15 mL) and antifoam agent
(Phenol Red, 5% w/w, 1 mL) and extracted with dichlo-
romethane. After mixing by vortex and separation of the
phases by centrifugation, the organic phase was trans-
ferred to a glass tube and the volume of the solvent was
evaporated. The residue was dissolved in 1 mL toluene
from which a 2 μl splitless injection was made on a
Hewlett Packard model HP5890A gas chromatograph
(Agilent Technologies, Atlanta, GA, USA), equipped
with an Nitrogen Phosphorus Detector (NPD).
Sample size calculation
For the sample size calculation we used the previously
reported concentrations of pyrene in air for Hanoi [8], a
half life of 1-OHP of 3.9 hours (see also Table 2) [28],
and we assumed that the participants are compliant in
wearing their masks during their work. The total inhaled
volume over 8 hours was estimated to be 2880 L, the
daily urinary excretion 2 L, and the pyrene intake to
range from 104 to 789 ng/8 hours. Assuming that the
Table 2 Baseline OH-PAHs levels (ng/g creatinine) and OH-PAHs’ half-lives from reference 27
OH-PAH Median half-life t 1/2, from ref 27 Size Median ng/g creat IQR*
1-hydroxynaphthalene 4.3 44 6172 4297 - 11220
1-hydroxyphenanthrene 5.1 44 562 418 - 839
1-hydroxypyrene 3.9 44 1020 604 - 1551
2-hydroxyfluorene 2.9 44 811 575 - 1106
2-hydroxynaphthalene 2.5 44 7051 5138 - 11820
2-hydroxyphenanthrene 3.9 44 358 254 - 534
3-hydroxyfluororene 6.1 44 284 162 - 450
3-hydroxyphenanthrene 4.1 44 475 288 - 833
4-hydroxyphenanthrene 3.5 44 102 75 - 146
9-hydroxyfluorene 3.1 44 1400 1018 - 1822
*IQR: interquartile range.
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rene intake is minimal (i.e. 104 ng) and that the baseline
1-OHP level is 30 ng/L, then urinary 1-OHP will be
82 ng/L (104 ng/2 L + 30 ng/L) without a respirator and
35.2 ng/L ([104 ng × 0.1]/2 L + 30 ng/L) with a respi-
rator. Assuming that the within-subject standard devia-
tion of a measurement is of similar size as the respirator
effect (corresponding to 0.85 on the natural log-scale)
and a two-sided alpha level of 0.05, a total of 24 subjects
would attain a power of 90% for a two-period cross-over
trial and even higher for our 4-period design. Due to
expected large variations in dietary intake and other pos-








female 12 (54.5%) 8 (36.4%) 20 (45.5%)
male 10 (45.5%) 14 (63.6%) 24 (54.5%)
Age (median, IQR) 42.5 (35–55) 39 (29–50) 40 (31–51)
Occupation (n,%)
motorbike driver 6 (27.3%) 11 (50.0%) 17 (38.6%)
street vendor 9 (40.9%) 6 (27.3%) 13 (34.1%)
other 7 (31.8%) 5 (22.7%) 12 (27.3%)
Other occupations were: security, bike repair, and other street-related work.Statistical analysis
An overall respirator effect on the urine concentration
of each measured metabolite was derived with a linear
mixed effect model which modeled follow-up measu-
rements as depending on the current intervention in
a period (respirator versus no respirator), the period
(4 periods in total) and a random subject effect (to account
for correlation of measurements within an individual).
The analysis was performed on all enrolled individuals
and repeated on the per protocol population after exclu-
ding subjects with positive cotinine at baseline as this sug-
gested active smoking or exposure to second hand smoke,
and periods where participants were non-compliant or
compliance status unknown. An adjusted analysis was
done where the model was additionally adjusted for age,
gender, occupation, and the baseline value of the me-
tabolite. All metabolites were log-transformed prior to
the analysis but mask effects were back-transformed
to the original scale after analysis, i.e. reported effects
are on the multiplicative scale. We also tested for carry-
over, i.e. mask effect-period interactions. All analyses
were performed with the free software R version 2.11.1
(R Foundation for Statistical Computing, Vienna, Austria).Results
Forty-four participants (54.5% male, median age 40 years)
were enrolled into the study from May to June, 2009
(see Table 3 for baseline characteristics and Figure 1 for
CONSORT flow diagram). The majority of the partici-
pants were motorbike drivers (38.6%) or street vendors
(36.5%). Other occupations were: security (6.8%), bike
repair (4.5%), and other work that was done on the
street (13.6%). None of the participants were known to
have chronic lung disease. Most participants lived close
to their work place (median: 0.5 km, IQR: 0.1-1.0 km).
During the day the participants travelled a median of
6 km per day (inter quartile range [IQR]: 2–100 km) and
spent a median of 10 hours (IQR: 8–12 hours) hours
outside on the street. The mean average monthly wage
was 1.6 million Vietnam dong (approximately 85 US$). In
Vietnamese cities it is common to wear a cloth mask on
the street. Before the study 40.9% never wore a mask,
27.3% sometimes, and 31.8% often. Most participants
(88.6%) complained that the R95 respirator was not com-
fortable. Other complaints were that the mask was too
tight (n = 2), painful (n = 2), or hard to breath through
(n = 1). Table 2 lists the median baseline urinary concen-
trations of OH-PAHs of all participants.
Figure 1 CONSORT flow diagram.
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During respirator periods, the study mask was worn for a
median of 7 hours per day (IQR: 6.5-8). One participant
wore the mask on one study day only for just 3 hours as
the mask was considered too tight and the participant
found it difficult to breath. One individual need to be cor-
rected in how to wear the mask as she was wearing it im-
properly during a visit. Few follow-up measurements were
missing. The only metabolites with >1 of the 176 follow-
up measurements missing were 1-hydroxynaphthaleneTable 4 Effect of mask wearing on PAH metabolites (multiplic
PAH metabolite Mask effect Mask effect (ad
1-hydroxynapthalene 0.86 (0.77,0.96); p = 0.007 0.86 (0.77,0.96); p
2-hydroxynapthalene 0.95 (0.84,1.08); p = 0.42 0.95 (0.84,1.08);p
2-hydroxyfluorene 0.98 (0.9,1.07); p = 0.61 0.98 (0.9,10.07); p
3-hydroxyfluorene 0.97 (0.88, 1.06); p = 0.48 0.97 (0.88, 1.06);
9-hydroxyfluorene 0.94 (0.85, 1.04); p = 0.23 0.94 (0.85, 1.04); p
1-hydroxyphenanthrene 0.97 (0.89, 1.07); p = 0.58 0.98 (0.89, 1.08); p
2-hydroxyphenanthrene 1.02 (0.92, 1.12); p = 0.72 1.02 (0.93, 1.13); p
3-hydroxyphenanthrene 1.01 (0.92, 1.1); p = 0.88 1.01 (0.92, 1.11); p
4-hydroxyphenanthrene 0.96 (0.86, 1.08); p = 0.53 0.97 (0.86, 1.09); p
1-hydroxyprene 1.00 (0.92, 1.09); p = 0.98 1.00 (0.92, 1.09); p
Effects are displayed as estimate (95% confidence interval); p-value.(1-OHN; 4, 2.27%), 1-OHP (4, 2.27%), and 9-hydroxy-
fluorene (6, 3.41%). There was no evidence that wearing a
R95 respirator affected the primary endpoint of the uri-
nary concentration of 1-OHP (Table 4, Figure 2). Moreover,
the lower confidence limit for the mask effect excluded an
average lowering of 1-OHP concentration due to mask
wearing by more than 8%. Results for the adjusted analysis
and per protocol analysis (n = 39 as cotinine was detected
in the urine of 4 volunteers and one volunteer had







= 0.007 0.87 (0.77,0.98); p = 0.02 p = 0.38 p = 0.85
= 0.47 0.96 (0.83,1.1); p = 0.54 p = 0.41 p = 0.98
= 0.66 0.97 (0.88,1.07); p = 0.58 p = 0.34 p = 0.56
p = 0.5 0.97 (0.87, 1.08); p = 0.58 p = 0.05 p = 0.6
= 0.22 0.95 (0.85, 1.06); p = 0.33 p < 0.001 p = 0.59
= 0.66 0.98 (0.88, 1.08); p = 0.65 p = 0.11 p-0.59
= 0.67 1.02 (0.91, 1.14); p = 0.74 p = 0.45 p = 0.15
= 0.85 1.03 (0.93, 1.14); p = 0.6 p = 0.69 p = 0.63
= 0.59 0.97 (0.86, 1.1); p = 0.66 p = 0.01 p = 0.46
= 0.96 1.01 (0.92, 1.11); p = 0.84 p < 0.001 p = 0.42
Figure 2 Figures for 1-OHN (panel A) and 1-OHP (panel B) line plots of values for each patient with overlaid boxplots and scatterplots
of values with mask versus those without mask (if values without mask are higher, most points of the scatterplot should be above the
diagonal). A: wore study mask; B: did not wear study mask.
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were consistent with the main analysis (Table 4). There was
also no evidence of a carry-over effect (p = 0.42); however,
there was a significant period effect (p < 0.001), which was
mainly due to higher measurements in period 3 in both
groups (Figure 2). There was also no evidence for a mask
effect for any of the other metabolites except for 1-OHN.Table 5 Comparison of urinary concentrations (ng/g) of 1-OH







Street workers (this study) Vietnam 2For 1-OHN, the measurements with mask were on average
by a factor of 0.86 (95% CI 0.77 to 0.96) lower.
Discussion
Our data show that the overall levels of PAH metabolites
in the urine of Hanoi street workers were very high, in-
dicating that there is high exposure to PAHs in HanoiP in Hanoi to other non-occupational populations
])
group Size Median 1-OHP level
(5-95th percentile)
20 1625 41 (15–233)
an 23 129 58 (19–212)
20 495 88 (22–362)
na 140 174 (39–617)
2 - 81 327 149 (52–654)
9 - 55 44 1020 (416–3453)
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other non-occupational populations are provided and
compared to our Hanoi data, showing that levels were
for example 24-fold higher than a studied USA popula-
tion. The levels found are not as high as those found in
workers in the petrochemical industry, particularly coke-
oven workers [30]. These data, together with the known
high levels of PAHs in ambient air in Hanoi, suggest that
inhalation is the main route of exposure. Despite this, in
this study with a relative small sample size we were not
able to demonstrate an effect of the mask on urine con-
centrations of OH-PAHs.
With the exception of 1-OHN, no effect was seen on
urine OH-PAH levels by wearing the study mask. In the
case of 1-OHN, inhalation would be the overall main
route of exposure [31]. However, for 2-OHN no effect
was seen, indicating this may be a chance finding as ten
metabolites were analyzed in this study. As urinary OH-
PAH measures total PAH exposure, other sources of ex-
posure need to be considered that may explain the lack
of effect of the study mask. Possible explanations are:
(1) high exposure to vapour phase PAHs that are not fil-
tered efficiently by the mask [8,23], (2) high PAH expo-
sure outside working hours when not wearing the mask,
(3) masks were not worn for a sufficient number of con-
secutive days to allow for sufficient clearance time for
inhaled PAHs to be excreted by the urine at the end of the
mask-wearing period or non-compliance or improper fit,
(4) other exposure sources such as dermal and ingestion
exposure, and (5) the mask was only tested in a short time
period in a single season, which may affect the results.
The average concentrations of 47 PAHs in Hanoi
in 2005 were: 63 ± 82 ngm-3 in particulate matter and
480 ± 300 ngm-3 in the vapour phase [8]. Also the PAHs
of which we assessed the metabolites in the urine were
more abundant in vapour phase, than in particulate mat-
ter. High molecular weight PAHs are predominantly
adsorbed on soot and particulate matter and the amount
present in the vapor phase is dependent upon the spe-
cific PAH and other properties such as temperature and
concentration [32]. The PAH levels in particulate matter
and vapour-phase in Hanoi at the time of the study was
not assessed. This is an important limitation of the study
because the R95 respirator used was only designed to
filter out particulate matter and not vapour-phase PAHs.
Though the masks did have activated carbon, this would
not be sufficient to filter out vapour-phase PAHs [23].
It is highly possible that the participants were exposed
to high levels of PAHs when they were not wearing the
mask. This is because the participants lived close to their
working place and according to the study protocol they
were only required to wear the mask during working
hours. Data from the Swiss-Vietnam Clean Air Program
show that pollution is heaviest at the roadside of mainroads where our participants typically worked and less
in the residential areas (Swiss-Vietnam Clean Air Pro-
gram, unpublished results). Still, the exposure during
off-work hours is likely to be high, which may have had
an impact on the measured OH-PAHs levels in the
urine. Furthermore, non-compliance or improper mask
fits may have influenced the results. This study was per-
formed in a non-regulated setting where it is difficult to
monitor compliance. However, visits by study staff did
show that the masks were worn properly, except for one
case.
Other potential sources of PAHs that could have in-
fluenced our results include: grilled food, cigarette smoke,
and dermal exposure. With questionnaires, the volunteers
were asked about these potential sources and cotinine
levels were measured. In four cases we detected cotinine
in the urine and excluded them from the per-protocol
analysis, but this did not alter the results. No subject
reported eating barbecued or grilled food during the study
period. Significant dermal exposure in people exposed to
urban ambient air pollution is unlikely, as this is generally
considered a risk in those working in particular industries
with dermal exposure to oil compounds [33].
As stated earlier, we cannot rule out, that subjects
were exposed to significant levels of PAHs at home and
while sleeping, and therefore, the study subjects may
have had limited time for clearance of PAH exposure
from the body between their work shifts. Furthermore,
the two days of wearing the respirator may not have
been sufficient, since the half-lives of PAHs vary in dif-
ferent reports and can exceed 24 hours [25]. Furthermore,
the two days may also not be sufficient for clearance as
the OH-PAH exposure of our participants was not a single
exposure, but continuous [28]. Ingestion exposures are re-
portedly lower than dermal or inhalation exposures [28].
As far as we know this is the first randomized in-
tervention study using respirators to reduce exposure to
PAHs in a non-occupational community setting. Most
studies are performed in occupational settings for which
good guidelines for intervention study designs have been
developed (see also: http://www.aiha.org/insideaiha/
volunteergroups/RPC/Documents/rpc-terms.pdf ) [34].
One study in 1996, assessed PAH biomarkers in urine in
89 Bangkok police officers working in traffic. This study
did report a reduction in biomarkers by wearing a simple
face masks while they were on duty for a week [35]. Other
studies using particulate respirators in occupational set-
tings showed a reduction in OH-PAH levels in the urine
[20-22]. None of these studies had a randomized design.
These studies state that the masks protect against the
PAH bound to particulate matters as reported in another
study by Alexandrie et al. [36].
One of the key differences with this study is that in all
studies the workers wore the masks for a longer time
Wertheim et al. Environmental Health 2012, 11:72 Page 8 of 9
http://www.ehjournal.net/content/11/1/72period. It is recommended that in subsequent studies
the mask should be worn for a longer consecutive period
and preferably in various climate conditions that cause
variation in pollution levels. Furthermore, respirators that
can also filter vapour phase PAHs need to be considered
in future studies in this setting. The only qualitative mea-
sure we had that did show a mask effect was that some
motorbike drivers anecdotally reported that when they
wore the study mask they had less respiratory symptoms
after a day of work. But this information was not sup-
ported by what was reported in the diaries.
Conclusions
The concentrations of OH-PAHs in the urine (pollution
biomarkers) were extremely high in Hanoi street wor-
kers. These high levels warrant further intervention stu-
dies to mitigate the health risks related to air pollution. In
this demonstration study, no effect was seen on urine
OH-PAH levels by wearing R95 masks during work hours
for two days in Hanoi, except for 1-OHN. It is recom-
mended that in subsequent studies the mask should be
worn for a longer consecutive period and preferably in
various climate conditions that cause variation in pollu-
tion levels. Furthermore, respirators that can also filter
vapour phase PAHs need to be considered in future
studies in this setting.
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